Terms: = Sarcomas AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Prognosis
34 results:
1. Association of hypoxia-inducible factor 1 expressions with prognosis role as a survival prognostic biomarker in the patients with osteosarcoma: a meta-analysis.
Khojastehnezhad MA; Seyedi SMR; Raoufi F; Asoodeh A
Expert Rev Mol Diagn; 2022 Dec; 22(12):1099-1106. PubMed ID: 36510847
[TBL] [Abstract] [Full Text] [Related]
2. Activation of PGRN/MAPK axis stimulated by the hypoxia-conditioned mesenchymal stem cell-derived HIF-1α facilitates osteosarcoma progression.
Shang C; Ou X; Zhang H; Wei D; Wang Q; Li G
Exp Cell Res; 2022 Dec; 421(1):113373. PubMed ID: 36183781
[TBL] [Abstract] [Full Text] [Related]
3. HIF-1α-mediated augmentation of miRNA-18b-5p facilitates proliferation and metastasis in osteosarcoma through attenuation PHF2.
Luo P; Zhang YD; He F; Tong CJ; Liu K; Liu H; Zhu SZ; Luo JZ; Yuan B
Sci Rep; 2022 Jun; 12(1):10398. PubMed ID: 35729160
[TBL] [Abstract] [Full Text] [Related]
4. Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors.
Fujiwara S; Kawamoto T; Kawakami Y; Koterazawa Y; Hara H; Takemori T; Kitayama K; Yahiro S; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Koyanagi-Aoi M; Aoi T; Kuroda R; Akisue T
Stem Cell Res Ther; 2020 Oct; 11(1):429. PubMed ID: 33008481
[TBL] [Abstract] [Full Text] [Related]
5. HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21.
Ren Z; Hu Y; Li G; Kang Y; Liu Y; Zhao H
Biomed Pharmacother; 2019 Sep; 117():109104. PubMed ID: 31228799
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA Taurine upregulated gene 1 promotes osteosarcoma cell metastasis by mediating HIF-1α via miR-143-5p.
Yu X; Hu L; Li S; Shen J; Wang D; Xu R; Yang H
Cell Death Dis; 2019 Mar; 10(4):280. PubMed ID: 30911001
[TBL] [Abstract] [Full Text] [Related]
7. Hypoxia accelerates the progression of angiosarcoma through the regulation of angiosarcoma cells and tumor microenvironment.
Maeda-Otsuka S; Kajihara I; Tasaki Y; Yamada-Kanazawa S; Sakamoto R; Sawamura S; Masuzawa M; Masuzawa M; Amoh Y; Hoshina D; Abe R; Komohara Y; Ihn H
J Dermatol Sci; 2019 Feb; 93(2):123-132. PubMed ID: 30704938
[TBL] [Abstract] [Full Text] [Related]
8. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently.
Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863
[TBL] [Abstract] [Full Text] [Related]
9. Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis.
Zhang T; Kastrenopoulou A; Larrouture Q; Athanasou NA; Knowles HJ
BMC Cancer; 2018 May; 18(1):536. PubMed ID: 29739381
[TBL] [Abstract] [Full Text] [Related]
10. The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma.
Forker L; Gaunt P; Sioletic S; Shenjere P; Potter R; Roberts D; Irlam J; Valentine H; Hughes D; Hughes A; Billingham L; Grimer R; Seddon B; Choudhury A; Robinson M; West CML
Br J Cancer; 2018 Mar; 118(5):698-704. PubMed ID: 29235571
[TBL] [Abstract] [Full Text] [Related]
11. Targeting the long noncoding RNA MALAT1 blocks the pro-angiogenic effects of osteosarcoma and suppresses tumour growth.
Zhang ZC; Tang C; Dong Y; Zhang J; Yuan T; Tao SC; Li XL
Int J Biol Sci; 2017; 13(11):1398-1408. PubMed ID: 29209144
[TBL] [Abstract] [Full Text] [Related]
12. Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma.
Shrestha P; Davis DA; Veeranna RP; Carey RF; Viollet C; Yarchoan R
PLoS Pathog; 2017 Sep; 13(9):e1006628. PubMed ID: 28922425
[TBL] [Abstract] [Full Text] [Related]
13. Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor.
Fukushima S; Endo M; Matsumoto Y; Fukushi JI; Matsunobu T; Kawaguchi KI; Setsu N; IIda K; Yokoyama N; Nakagawa M; Yahiro K; Oda Y; Iwamoto Y; Nakashima Y
PLoS One; 2017; 12(5):e0178064. PubMed ID: 28558056
[TBL] [Abstract] [Full Text] [Related]
14. Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α.
Keremu A; Aini A; Maimaitirexiati Y; Liang Z; Aila P; Xierela P; Tusun A; Moming H; Yusufu A
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 28442599
[TBL] [Abstract] [Full Text] [Related]
15. Hypoxia as a Biomarker and for Personalized Radiation Oncology.
Vordermark D; Horsman MR
Recent Results Cancer Res; 2016; 198():123-42. PubMed ID: 27318684
[TBL] [Abstract] [Full Text] [Related]
16. High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma.
Chang YL; Yang CY; Lin MW; Wu CT; Yang PC
Eur J Cancer; 2016 Jun; 60():125-35. PubMed ID: 27107327
[TBL] [Abstract] [Full Text] [Related]
17. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
Zhu KP; Zhang CL; Shen GQ; Zhu ZS
Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
[TBL] [Abstract] [Full Text] [Related]
18. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas.
Hu T; He N; Yang Y; Yin C; Sang N; Yang Q
J Exp Clin Cancer Res; 2015 Feb; 34(1):22. PubMed ID: 25884381
[TBL] [Abstract] [Full Text] [Related]
19. MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3α.
Gits CM; van Kuijk PF; de Rijck JC; Muskens N; Jonkers MB; van IJcken WF; Mathijssen RH; Verweij J; Sleijfer S; Wiemer EA
BMC Cancer; 2014 Jun; 14():429. PubMed ID: 24927770
[TBL] [Abstract] [Full Text] [Related]
20. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract] [Full Text] [Related]
[Next]
